	Pharmacokinetic model selection for infliximab based on inflammatory bowel disease phenotype and severity: Toward model-informed precision dosing. PLoS One Hom, Jovanovi, Markovi, Vezmar Kova, Kne, Kralj , Svorcan P, Vu. PMID: 42497217 [PubMed - indexed for MEDLINE]
	Effects of cuproptosis and its application in inflammatory bowel disease (Review). Int J Mol Med Chen L, Akanyibah FA, Guan J, Pei B, Wang B, Mao F. PMID: 42495776 [PubMed - indexed for MEDLINE]
	Long-Term Outcomes After Stoma Creation in Crohn's Disease: A Retrospective Cohort Study of 422 Patients. Ann Gastroenterol Surg Nagano K, Kuwahara R, Tomoo Y, Kusunoki K, Horio Y, Kimura K, Kataoka K, Ikeda M, Uchino M, Ikeuchi H. PMID: 42495659 [PubMed - as supplied by publisher]
	Mechanistic remodeling and immunoregulatory functions of the B cell-humoral immunity axis in inflammatory bowel disease. Front Immunol Zhang T, Ren Z, Zhang H, Pan Z, Chen M, Bu S, Cheng X, Peng J, Yu Y. PMID: 42495645 [PubMed - indexed for MEDLINE]
	Serum immune profiling suggests overlap between IBD patients with joint complaints and patients with spondyloarthritis. Front Immunol Veltkamp SHC, van Gaalen FA, de Bruin LJE, van Erp SJ, Samsom JN, van der Meulen-de Jong AE, Voorneveld PW. PMID: 42495644 [PubMed - indexed for MEDLINE]
	Tofacitinib as Rescue Therapy in Steroid-Refractory Acute Severe Ulcerative Colitis: A Retrospective Cohort Study with Observations on Cytomegalovirus Coinfection. Cureus Banerjee S, Yadav D, Gupta A, Kumar U, Shukla S, Kumar V, Tiwari AK, Kumar VM, Singla A, Patel NK. PMID: 42495474 [PubMed]
	Evaluating objective nutritional biomarkers for the prediction of sarcopenia in Crohn's disease: development and internal validation of a clinical nomogram. Front Nutr Zhong HY, Deng WT, Huang JS, Li JC, Luo XL, Liang CM, Xiong G, Lai MY. PMID: 42494765 [PubMed]
	Rectal stump management in paediatric ulcerative colitis-An international survey for the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition PORTO Inflammatory Bowel Disease group study. JPGN Rep Gordon B, Cooper S, Bourke B, Hussey S. PMID: 42494430 [PubMed - as supplied by publisher]
	Proactive therapeutic drug monitoring of infliximab leads to treatment durability in paediatric Crohn's disease: A single-centre Australian experience. JPGN Rep Chuah CW, Eldredge J, Magoffin A, O'Loughlin EV, Park CJ, Puppi J, Siew S, Stormon M, Thacker K, Dutt S. PMID: 42494426 [PubMed - as supplied by publisher]
	Pharmacogenetic Risk Factors for Thiopurine-Induced Leukopenia in Patients with Inflammatory Bowel Disease. Yonsei Med J Boo EK, Yu J, Oh S, Cheon JH, Kim JH. PMID: 42494268 [PubMed - indexed for MEDLINE]
	Risk factors for endoscopic recurrence after ileocolonic resection in Crohn's disease: A meta-analysis. Curr Probl Surg Pan L, Yu S, Sun S, Li J. PMID: 42493162 [PubMed - in process]
	Microbial predictors of sustained clinical remission following the Crohn's disease exclusion diet in adults and microbiome shifts toward healthy pediatric controls. Crohns Colitis 360 Sigall-Boneh R, Organ S, Ghiboub M, Yanai H, Abramas L, Wierdsma N, Verburgt CM, de Jonge WJ, Derikx JPM, Lewis JD, Gu H, Bielawski J, Maharshak N, Dotan I, Wine E, Dunn K, Van Limbergen J. PMID: 42491760 [PubMed]
	Effect of continuity of patient care on quality of life and psychological state in patients with inflammatory bowel disease: a systematic review and meta-analysis of randomized controlled trials. PeerJ Huang XR, Duan H, Zhou XX, Wang M, Wang J. PMID: 42491667 [PubMed - indexed for MEDLINE]
	Emerging role of intestinal ultrasound in detecting postoperative recurrence in Crohn's disease. Gastroenterol Rep (Oxf) Fanizzi F, D'Amico F, Zilli A, Parigi TL, Solitano V, Furfaro F, Peyrin-Biroulet L, Danese S, Allocca M. PMID: 42490826 [PubMed]
	Effectiveness and Safety of Risankizumab in Crohn Disease After Failure of a First Line of Advanced Therapy: A Long-Term, Real-Life Study. Am J Ther Tursi A, Mocci G, Scaldaferri F, Napolitano D, Gaiani F, De' Angelis G, Giuseppe Ribaldone D, Schillaci E, Savarino EV, Barba CDE, Bendia E, Bolognini L, Balducci D, Quatraccioni C, Martini F, Montori M, Giovanni Maconi, Cataletti G, Massari A, Del Zanna E, Costa F, Ceccarelli L, Gravina AG, Pellegrino R, Bodini G, Pasta A, Marzo M, Miranda A, Cuomo A, Donnarumma L, Lombardi G, Patturelli M, Serio M, Antonella Scarcelli, Pranzo G, Chiara Maria Palmisano, Rocco Spagnuolo, Luzza F, Morano D, Vespere G, Sedda S, Luca LDE, Elisei W, Monterubbianesi R, Di Fonzo M, Fanigliulo L, Pica R, Cassieri C, Cocco A, Stasi E, Grossi L, Bertani L, Cortellini F, Piergallini S, Scarozza P, Bevevino G, Zerboni G, Iacopini F, Rodino' S, Sebkova L, Checchin D, Lamboglia F, Ferrara F, Della Valle N, Colucci R, Bachetti F, Catarella D, D'agostino D, Bartolo EDI, Luppino I, Erboso M, Rocco G, Sacchi C, Zampaletta C, Giacomo Forti, Fiorella S, Bassotti G, Antonelli E, Mucherino C, D'Antonio E, Montesano L, Giovannone M, Vincoli G, Gigliozzi A, D'Ascoli B, Rizzi M, Capone P, Aragona G, Perazzo P, Allegretta L, Tonti P, Neve V, Pagnini C, Grandolfo A, Gatti F, Bucci A, Rizzi M, Picchio M, Onidi FM, Usai Satta P, Papa A. PMID: 42490306 [PubMed - as supplied by publisher]
	Case Report: Dupilumab-associated ulcerative colitis: elucidating the pathomechanistic link between Th2 blockade and Th17 polarized intestinal inflammation. Front Immunol Fu F, Zhao Q, Ma L, Wang A, Wang Z, Xu X. PMID: 42488642 [PubMed - indexed for MEDLINE]
	Subcutaneous infliximab in the treatment of patients with perianal fistulizing Crohn's disease: current evidence and emerging roles. Ther Adv Gastroenterol Dignass A, Reenaers C, Buisson A, Magro F, Vuitton L, Park S, Park MJ, Sands BE. PMID: 42488031 [PubMed]
	New Diagnostic Criteria for Acute Severe Ulcerative Colitis in the Modern Treatment Era: A Modified Delphi Consensus by REFINED-ASUC. Clin Gastroenterol Hepatol Raine T, Peyrin-Biroulet L, Begun J, Biedermann L, Blumenstein I, Cheifetz AS, Colombel JF, Dulai PS, Gecse KB, Jairath V, Nakase H, Panaccione R, Reinisch W, Verstockt B, Higgins PDR. PMID: 42486394 [PubMed - as supplied by publisher]
	Upadacitinib as a rescue therapy for steroid- and infliximab-refractory acute severe ulcerative colitis: short- and long-term effectiveness and safety in a multicenter cohort study. Inflamm Bowel Dis Ünal NG, Bakkalo, Kav T, E, Kani HT, Akp, Ak, Da, , Büyüktorun , Barutçu S, K, Bengi G, Çavu, Oruç N, Alahdab YÖ, Atu, Dinçer D, Karakan T, Hatemi A, Erzin YZ, Tezel A, Törüner M, Akyüz F, Çelik AF. PMID: 42485228 [PubMed - as supplied by publisher]
	External validation of a prediction score for identifying a mild course of Crohn's disease. Eur J Gastroenterol Hepatol Couto Sousa D, Fernandes SR, Da Silva Neves A, Pereira F, Bronze S, Coelho Rodrigues I, Saraiva S, Gonçalves AR, Valente A, Correia L. PMID: 42485128 [PubMed - as supplied by publisher]

Articles 1 - 20 / 58361

Page 1 of 2919



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy